111 related articles for article (PubMed ID: 14576486)
1. Neoplasms derived from plasmacytoid monocytes/interferon-producing cells: variability of CD56 and granzyme B expression.
Facchetti F; Vermi W; Santoro A; Vergoni F; Chilosi M; Doglioni C
Am J Surg Pathol; 2003 Nov; 27(11):1489-92; author reply 1492-3. PubMed ID: 14576486
[No Abstract] [Full Text] [Related]
2. Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes/interferon-producing cells associated with myeloid disorders.
Vermi W; Facchetti F; Rosati S; Vergoni F; Rossi E; Festa S; Remotti D; Grigolato P; Massarelli G; Frizzera G
Am J Surg Pathol; 2004 May; 28(5):585-95. PubMed ID: 15105645
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotypic CD56 Variation Within a Single Patient With Blastic Plasmacytoid Dendritic Cell Neoplasm.
Lopez AT; Shaw KS; Yamany T; Husain S; Geskin L
JAMA Dermatol; 2018 Apr; 154(4):492-494. PubMed ID: 29490374
[No Abstract] [Full Text] [Related]
4. Massive central nervous system infiltration by CD56-positive plasma cells in multiple myeloma.
Lopes AC; Xavier FD; de Souza Barroso R; Gomes HR; Sales MM
Cytopathology; 2017 Apr; 28(2):172-174. PubMed ID: 27489145
[No Abstract] [Full Text] [Related]
5. Apoptosis of human endometrium mediated by perforin and granzyme B of NK cells and cytotoxic T lymphocytes.
Konno R; Igarashi T; Okamoto S; Sato S; Moriya T; Sasano H; Yajima A
Tohoku J Exp Med; 1999 Feb; 187(2):149-55. PubMed ID: 10228986
[TBL] [Abstract][Full Text] [Related]
6. CD56+ putative natural killer cell lymphomas: production of cytolytic effectors and related proteins mediating tumor cell apoptosis?
Ng CS; Lo ST; Chan JK; Chan WC
Hum Pathol; 1997 Nov; 28(11):1276-82. PubMed ID: 9385933
[TBL] [Abstract][Full Text] [Related]
7. Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients.
Kagami Y; Suzuki R; Taji H; Yatabe Y; Takeuchi T; Maeda S; Kondo E; Kojima M; Motoori T; Mizoguchi Y; Okamoto M; Ohnishi K; Yamabe H; Seto M; Ogura M; Koshikawa T; Takahashi T; Kurita S; Morishima Y; Suchi T; Nakamura S
Am J Surg Pathol; 1999 Oct; 23(10):1184-200. PubMed ID: 10524519
[TBL] [Abstract][Full Text] [Related]
8. Distinct granzyme expression in human CD3- CD56+ large granular- and CD3- CD56+ small high density-lymphocytes displaying non-MHC-restricted cytolytic activity.
Smyth MJ; Browne KA; Kinnear BF; Trapani JA; Warren HS
J Leukoc Biol; 1995 Jan; 57(1):88-93. PubMed ID: 7530284
[TBL] [Abstract][Full Text] [Related]
9. Infantile CD4+/CD56+ hematodermic neoplasm.
Hu SC; Tsai KB; Chen GS; Chen PH
Haematologica; 2007 Sep; 92(9):e91-3. PubMed ID: 17768139
[No Abstract] [Full Text] [Related]
10. Granzyme B immunoreactivity in T/natural killer cell lymphomas.
Cho MS; Lee MK; Yang WI; Yoon JH
Yonsei Med J; 1997 Oct; 38(5):285-93. PubMed ID: 9409191
[TBL] [Abstract][Full Text] [Related]
11. CD4(+) CD56(+) lineage-negative malignancies are rare tumors of plasmacytoid dendritic cells.
Reichard KK; Burks EJ; Foucar MK; Wilson CS; Viswanatha DS; Hozier JC; Larson RS
Am J Surg Pathol; 2005 Oct; 29(10):1274-83. PubMed ID: 16160468
[TBL] [Abstract][Full Text] [Related]
12. Acute Myeloid Leukemia With MLL Rearrangement and CD4+/CD56+ Expression can be Misdiagnosed as Blastic Plasmacytoid Dendritic Cell Neoplasm: Two Case Reports.
Lee JM; Kim IS; Lee JN; Park SH; Kim HH; Chang CL; Lee EY; Kim HR; Oh SH; Song SA
Ann Lab Med; 2016 Sep; 36(5):494-7. PubMed ID: 27374717
[No Abstract] [Full Text] [Related]
13. CD56
Jaime P; García-Guerrero N; Estella R; Pardo J; García-Álvarez F; Martinez-Lostao L
Osteoarthritis Cartilage; 2017 Oct; 25(10):1708-1718. PubMed ID: 28668542
[TBL] [Abstract][Full Text] [Related]
14. Localization and identification of granzymes A and B-expressing cells in normal human lymphoid tissue and peripheral blood.
Kummer JA; Kamp AM; Tadema TM; Vos W; Meijer CJ; Hack CE
Clin Exp Immunol; 1995 Apr; 100(1):164-72. PubMed ID: 7697916
[TBL] [Abstract][Full Text] [Related]
15. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells.
Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I
Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057
[TBL] [Abstract][Full Text] [Related]
16. G-CSF-mobilized CD34+ cells cultured in interleukin-2 and stem cell factor generate a phenotypically novel monocyte.
Sconocchia G; Fujiwara H; Rezvani K; Keyvanfar K; El Ouriaghli F; Grube M; Melenhorst J; Hensel N; Barrett AJ
J Leukoc Biol; 2004 Dec; 76(6):1214-9. PubMed ID: 15345723
[TBL] [Abstract][Full Text] [Related]
17. Cutting edge: cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression.
Pittet MJ; Speiser DE; Valmori D; Cerottini JC; Romero P
J Immunol; 2000 Feb; 164(3):1148-52. PubMed ID: 10640724
[TBL] [Abstract][Full Text] [Related]
18. Detection of Minimal Bone Marrow involvement of Blastic Plasmacytoid Dendritic Cell Neoplastic Cells - CD303 immunostaining as a diagnostic tool.
Ohe R; Aung NY; Shiono Y; Utsunomiya A; Kabasawa T; Tamazawa N; Tamura Y; Kato T; Yamada A; Hasegawa S; Aizawa K; Inokura K; Ito S; Toubai T; Kato Y; Tsunoda T; Onami K; Suzuki T; Ishizawa K; Yamakawa M
J Clin Exp Hematop; 2018 Mar; 58(1):1-9. PubMed ID: 29415975
[TBL] [Abstract][Full Text] [Related]
19. The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment.
Guillot B; Portalès P; Thanh AD; Merlet S; Dereure O; Clot J; Corbeau P
Br J Dermatol; 2005 Apr; 152(4):690-6. PubMed ID: 15840100
[TBL] [Abstract][Full Text] [Related]
20. CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms.
O'Connell FP; Pinkus JL; Pinkus GS
Am J Clin Pathol; 2004 Feb; 121(2):254-63. PubMed ID: 14983940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
